Biomarin Pharmaceutical (BMRN) Short-term Investments (2009 - 2025)
Biomarin Pharmaceutical (BMRN) posted Short-term Investments of $248.93 million for Q4 2025, up 27.7% from $194.86 million a year earlier and up 9.3% from the prior quarter.
Biomarin Pharmaceutical (BMRN) Short-term Investments (2009 - 2025) Analysis & Trends
Since Q4 2009, Biomarin Pharmaceutical has reported Short-term Investments for 64 quarters.
- Annual Short-term Investments shows a five-year compound annual growth rate of -9.8% (FY2020 to FY2025).
- In prior years, Biomarin Pharmaceutical's Short-term Investments was $194.86 million in FY2024 (-38.9%), $318.68 million in FY2023 (-43.8%), $567.01 million in FY2022 (+32.9%) and $426.6 million in FY2021 (+2.5%).
- The Q4 2025 figure stands as the highest quarterly Short-term Investments since Q3 2024.
- On a year-over-year basis, Short-term Investments increased in 1 of the last eight quarters, with an average decline of 22.6%.
- The strongest year-over-year quarter for Short-term Investments in the past five years was Q4 2022, with growth of 32.9%; the weakest was Q1 2024, with a decline of 47.6%.
- According to Business Quant data, Short-term Investments for the three prior quarters was $227.73 million (Q3 2025), $218.31 million (Q2 2025) and $223.53 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Biomarin Pharmaceutical | 11.07 Bn | 4.93 Bn | 786.91 Mn |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 248.93 Mn |
| Sep 30, 2025 | 227.73 Mn |
| Jun 30, 2025 | 218.31 Mn |
| Mar 31, 2025 | 223.53 Mn |
| Dec 31, 2024 | 194.86 Mn |
| Sep 30, 2024 | 255.00 Mn |
| Jun 30, 2024 | 252.20 Mn |
| Mar 31, 2024 | 299.58 Mn |
| Dec 31, 2023 | 318.68 Mn |
| Sep 30, 2023 | 340.43 Mn |
| Jun 30, 2023 | 476.58 Mn |
| Mar 31, 2023 | 572.02 Mn |
| Dec 31, 2022 | 567.01 Mn |
| Sep 30, 2022 | 512.25 Mn |
| Jun 30, 2022 | 489.95 Mn |
| Mar 31, 2022 | 450.80 Mn |
| Dec 31, 2021 | 426.60 Mn |
| Sep 30, 2021 | 462.33 Mn |
| Jun 30, 2021 | 481.86 Mn |
| Mar 31, 2021 | 420.18 Mn |
Biomarin Pharmaceutical Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=BMRN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();